The Company generated$3.3 billionof free cash flow in the third quarter of 2024 versus$2.5 billionin the third quarter of 2023, driven by business performance and timing of working capital items, partially offset by lower interest income. References in this release to "non-GAAP" measures, measu...
Amgen, which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $9.09 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 2.54%. This compares to year-ago revenues of $8.2 billion. The company has topped consensus revenue estima...
We expect that we will continue to increase our dividend. Let's turn to the outlook for the business for 2025 on Slide 31. We expect our 2025 total revenues in the range of 34.3 billion to 35.7 billion and non-GAAP earnings per share between $20 and $21.20. Our revenue range reflects ...
55% of revenue in FY 2024 came from strong-margin HVS. By: Charlie Sternberg Promotions & Moves Avalere Health Taps Amar Urhekar as CEO Urhekar joined Avalere Health in 2023 as Chief Operations Officer. By: Charlie Sternberg Breaking News AbbVie Acquires Aliada for $1.4B Acquisition adds ...
Total Revenue $33,424,000 $28,190,000 $26,323,000 $25,979,000 Cost of Revenue $12,858,000 $8,451,000 $6,406,000 $6,454,000 Gross Profit $20,566,000 $19,739,000 $19,917,000 $19,525,000 Operating Expenses Research and Development $5,964,000 $4,784,000 $4,434,000 $...
Dendreon: revenue forecast 2011-2014 Swiss biotech companies: profit 2016-2023 Share of global immunoglobulin therapies market 2017, by country Genentech: U.S. revenue by product 2008 Global biologics discovery market worldwide by phase 2016-2025 ...
Revenue (TTM)33.424B Gross Margin (TTM)61.53% Net Margin (TTM)12.24% Debt To Equity (MRQ)1,022.61% EVENTS Earnings Date05/01/2025 Ex Div Date05/16/2025 Div Amount2.38 Split Date- Split Factor- Profile MORE Amgen Inc. is a biotechnology company. It discovers, develops, manufactures and ...
AMGN Stock Earnings: Amgen Beats EPS, Beats Revenue for Q1 2024 By InvestorPlace Earnings May 2, 2024 AMGN stock results show that Amgen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Ticking Time Bombs: 3 Dow Stocks to Dump While You...
Revenue in USD (TTM)33.42bn Net income in USD4.09bn Incorporated1986 Employees26.70k Location Amgen IncOne Amgen Center DriveTHOUSAND OAKS 91320United StatesUSA Phone+1 (805) 447-1000 Fax+1 (805) 447-1010 Websitehttps://www.amgen.com/ ...
Revenue$28.01B Net Income$6.72B 2023 Sales Growth7.35% Employees26,700 Board of Directors Wanda M. AustinIndependent Director Ellen Jamison KullmanIndependent Director Brian J. DrukerIndependent Director Charles M. Holley Jr.Independent Director